ET-1 induces proliferation in glioblastoma through various pathways including the mitogen-activated protein kinase (MAPK) pathway, and BQ788, an ETRB-specific receptor antagonist, blocks the phosphorylation of extracellular signal-related kinase, a key step in MAPK signaling [21]. This evidence concerns the gene EDN1 and glioblastoma.